| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 2.480 | 50.067 | 86.438 | 119.497 | 81.093 |
| Total Income - EUR | - | - | - | - | - | 2.480 | 50.067 | 86.438 | 119.501 | 81.093 |
| Total Expenses - EUR | - | - | - | - | - | 96 | 1.827 | 7.786 | 21.262 | 20.879 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 2.384 | 48.239 | 78.652 | 98.239 | 60.214 |
| Net Profit/Loss - EUR | - | - | - | - | - | 2.309 | 47.015 | 76.525 | 97.227 | 57.830 |
| Employees | - | - | - | - | - | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Medical Nirvana S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 140 | 0 | 28.175 | 20.203 | 12.248 |
| Current Assets | - | - | - | - | - | 2.317 | 48.040 | 73.425 | 89.659 | 71.132 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 0 | 12 | 56.538 | 78.376 | 45.436 |
| Cash | - | - | - | - | - | 2.317 | 48.028 | 16.888 | 11.283 | 25.696 |
| Shareholders Funds | - | - | - | - | - | 2.351 | 47.063 | 76.591 | 97.293 | 57.896 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 105 | 976 | 25.745 | 13.247 | 25.670 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Medical Nirvana S.r.l.